Publications
5674 Results
- Journal / Conference
- Oncologist Jun 3;29(6):e843-e847
- Year
- 2024
- Research Committee(s)
- Lung
- PMID
- PMID38597608
- PMC
- PMC11144964
- Study Number(s)
- LUNGMAP
A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol
- Journal / Conference
- Lancet Oncology Aug;25(8):1038-1052
- Year
- 2024
- Research Committee(s)
- Genitourinary
- PMID
- PMID38942046
- PMC
- PMC11323681
- Study Number(s)
- CTSU/EA8143
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
- Journal / Conference
- Journal of Clinical Oncology Jul 1;42(19):2295-2305
- Year
- 2024
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID38547438
- Study Number(s)
- CTSU/C80702
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
- Journal / Conference
- Studies in Health Technology and Informatics Aug 22:316:1368-1372
- Year
- 2024
- Research Committee(s)
- Multiple sites
Comparing the Accuracy of Traditional vs. FHIR®-based Extraction of Electronic Health Record Data for Two Clinical Trials
- Journal / Conference
- Translational Andrology and Urology Mar 31;13(3):458-462
- Year
- 2024
- Research Committee(s)
- Genitourinary
- PMID
- PMID38590957
- PMC
- PMC10999026
- Study Number(s)
- S1314
Biomarker challenges in the pursuit of personalized neoadjuvant chemotherapy for muscle-invasive bladder cancer: conclusions from SWOG S1314 [Editorial]
- Journal / Conference
- Journal of Thoracic Oncology Aug 5:S1556-0864(24)00751-2
- Year
- 2024
- Research Committee(s)
- Lung
- PMC
- PMID39111731
- Study Number(s)
- LUNGMAP, S1400
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
- Journal / Conference
- ESMO Congress (Sept 13-17, 2024, Barcelona Spain, poster; Annals of Oncology (2024) 35 (suppl_2): S802-S877. 10.1016/annonc/annonc1602
- Year
- 2024
- Research Committee(s)
- Lung
- Study Number(s)
- S1900A
A Genomic Scar Based Signature (HRDsig) and Biallelic BRCA Alterations Identify a Homologous Recombination Deficiency (HRD) Phenotype of Non-Small Cell Lung Cancer (NSCLC) Potentially Actionable to the PARP inhibitor Rucaparib: Post-Hoc Analysis of Lung-MAP Substudy S1900A
- Journal / Conference
- Journal of Clinical Oncology Nov 20;42(33):3911-3916
- Year
- 2024
- Research Committee(s)
- Genitourinary
- PMID
- PMID39255440
- Study Number(s)
- S1500
Final overall survival analysis of S1500: A randomized, phase II study comparing sunitinib to cabozantinib, crizotinib and savolitinib in advanced papillary renal cell carcinoma
- Journal / Conference
- Korean Society of Medical Oncology Meeting (September 26 to 27, 2024.Seoul, Korea), oral
- Year
- 2024
- Research Committee(s)
- Lung
- Study Number(s)
- S2302
Project Pragmatica: S2302 Pragmatica-Lung and its Application in rare cancers
- Journal / Conference
- New England Journal of Medicine Oct 3;391(13):1206-1216
- Year
- 2024
- Research Committee(s)
- Genitourinary
- PMID
- PMID39589370
- PMC
- PMC11599768
- Study Number(s)
- S1011